BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12818941)

  • 1. Target-controlled infusion of rocuronium in infants, children, and adults: a comparison of the pharmacokinetic and pharmacodynamic relationship.
    Saldien V; Vermeyen KM; Wuyts FL
    Anesth Analg; 2003 Jul; 97(1):44-9, table of contents. PubMed ID: 12818941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of real-time Bayesian forecasting of pharmacokinetic parameters on the precision of a rocuronium target-controlled infusion.
    Motamed C; Devys JM; Debaene B; Billard V
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1025-31. PubMed ID: 22349465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
    Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target controlled infusion of rocuronium: analysis of effect data to select a pharmacokinetic model.
    Vermeyen KM; Hoffmann VL; Saldien V
    Br J Anaesth; 2003 Feb; 90(2):183-8. PubMed ID: 12538375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children.
    Wierda JM; Meretoja OA; Taivainen T; Proost JH
    Br J Anaesth; 1997 Jun; 78(6):690-5. PubMed ID: 9215021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.
    McCoy EP; Mirakhur RK; Maddineni VR; Wierda JM; Proost JH
    Br J Anaesth; 1996 Jan; 76(1):29-33. PubMed ID: 8672375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response and concentration-response relation of rocuronium infusion during propofol-nitrous oxide and isoflurane-nitrous oxide anaesthesia.
    Kansanaho M; Olkkola KT; Wierda JM
    Eur J Anaesthesiol; 1997 Sep; 14(5):488-94. PubMed ID: 9303285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.
    Dragne A; Varin F; Plaud B; Donati F
    Can J Anaesth; 2002 Apr; 49(4):353-60. PubMed ID: 11927473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of rocuronium in young adult and elderly patients undergoing elective surgery.
    Varrique RM; Lauretti GR; Matsumoto JA; Lanchote VL; de Moraes NV
    J Pharm Pharmacol; 2016 Nov; 68(11):1351-1358. PubMed ID: 27545305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rocuronium in infants, children and adults during balanced anaesthesia.
    Taivainen T; Meretoja OA; Erkola O; Rautoma P; Juvakoski M
    Paediatr Anaesth; 1996; 6(4):271-5. PubMed ID: 8827742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.
    van Miert MM; Eastwood NB; Boyd AH; Parker CJ; Hunter JM
    Br J Clin Pharmacol; 1997 Aug; 44(2):139-44. PubMed ID: 9278198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T
    Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs.
    De Haes A; Proost JH; De Baets MH; Stassen MH; Houwertjes MC; Wierda JM
    Anesthesiology; 2003 Jan; 98(1):133-42. PubMed ID: 12502989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of mivacurium by rocuronium is age- and time-dependent: a study in children, adolescents, and young and elderly adults.
    Goudsouzian N; Martyn JA
    J Clin Pharmacol; 1997 Jul; 37(7):649-55. PubMed ID: 9243359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EC(50) of remifentanil to prevent withdrawal movement associated with injection of rocuronium.
    Yoon JY; Kim HK; Kwon JY; Shin SW; Kim KH; Kim WS; Kim TK
    J Anesth; 2010 Apr; 24(2):182-6. PubMed ID: 20127371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
    Sparr HJ; Khuenl-Brady KS; Eriksson LI
    Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target controlled infusion of rocuronium: selection of a pharmacokinetic model.
    Vermeyen KM; Hoffmann VL; Saldien V; Adriaensen HF
    Acta Anaesthesiol Belg; 2002; 53(1):17-9. PubMed ID: 11975424
    [No Abstract]   [Full Text] [Related]  

  • 18. Rocuronium bromide in the ICU: dose finding and pharmacokinetics.
    Khuenl-Brady KS; Sparr H; PĆ¼hringer F; Agoston S
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():79-80. PubMed ID: 8557012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of intramuscular rocuronium in infants and children.
    Reynolds LM; Lau M; Brown R; Luks A; Sharma M; Fisher DM
    Anesthesiology; 1997 Nov; 87(5):1096-105. PubMed ID: 9366462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuromuscular blocking effects, pharmacokinetics and safety of Org 9426 (rocuronium bromide) in Japanese patients].
    Suzuki T; Saeki S; Takeda J; Ozaki M; Iwao Y
    Masui; 2006 Apr; 55(4):419-27. PubMed ID: 16634542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.